MOTS-c: peptide of the week
What is MOTS-c?
MOTS-c is a 16-amino-acid peptide encoded by mitochondrial DNA — one of a small family of “mitochondrial-derived peptides.”
How it works
Research indicates it can move to the cell nucleus under stress and influence genes involved in metabolism, partly through the AMPK energy-sensing pathway.
What researchers are studying
- ●Exercise capacity and muscle metabolism in mice
- ●Cellular stress responses
- ●Age-related metabolic changes
Where the evidence stands: Not approved by the FDA. Human research is at an early stage.
Recent peer-reviewed research
- Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic PerformanceSports medicine (Auckland, N.Z.) · 2026 Aug · PubMed ↗
- Mitochondrial-Derived Peptide MOTS-c Suppresses Ovarian Cancer Progression by Attenuating USP7-Mediated LARS1 DeubiquitinationAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024 Nov · PubMed ↗
- Mitochondria-derived peptide MOTS-c and its role in OSA pathogenesis: a potential therapeutic target?Sleep and biological rhythms · 2025 Jul · PubMed ↗
New lab results that week
- AOD-9604 5mg · Mile High Compounds · Third-party labView report ↗
Every Monday: the week's price drops and restocks, new third-party lab results, and a plain-English research guide with the latest studies. No spam — unsubscribe anytime.
Educational content only — not medical advice. Prices reflect the week of publication; see the Price Index for current prices. Compounds referenced are sold by third parties for laboratory research use only. The Peptide Audit.